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the corresponding central components of prokaryotic fatty acid synthase complexes. Genomic deletions of
the two genes ACPM1 and ACPM2 in the strictly aerobic yeast Yarrowia lipolytica resulted in strains that were
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composition of the organelles were found. Proteomic analysis revealed that both ACPMs were tightly bound
to puriﬁed mitochondrial complex I. Western blot analysis revealed that the afﬁnity tagged ACPM1 and
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Acyl carrier proteins (ACPs) are small (∼10 kDa) acidic proteins
with highly conserved amino acid sequences. They are central
components of fatty acid synthase (FAS) complexes from bacteria
and organelles of bacterial origin (plant chloroplasts and mitochon-
dria), classiﬁed as FAS type II. In such enzymes, all steps in fatty acid
synthesis are carried out by separate polypeptides [1]. In this type of
FAS, acyl carrier protein functions to shuttle intermediates among
enzymes. The FAS type I complex is present in the cytosol of
eukaryotes [2,3] and is composed of one or two giant polypeptides
[4] containing all necessary enzymes for fatty acid synthesis with ACPbeing its central domain. In both systems ACP or ACP-like domains
contain a centrally located, serine-bound phosphopantethein pros-
thetic group. This group is post-translationally attached and serves as
a platform for the acyl intermediates during fatty acid synthesis.
Additional postulated functions for bacterial ACPs involve synthesis of
polyketides [5], peptide antibiotics [6] and acylation of toxins [7].
One or several ACPs of the bacterial FAS type II have been found in
mitochondria of several species, including Neurospora crassa [8,9],
bovine heart [10] and Arabidopsis thaliana [11]. These proteins are
denoted ACPM for “Acyl Carrier Protein,Mitochondrial”. Mitochondria
of N. crassa were found to contain a protein which was labelled with
[14C] pantothenic acid and carried an acyl group [8]. Evidence for a
covalently attached pantetheine-4′-phosphate in bovine ACPM [10]
was obtained by electrospray mass spectrometry, before and after
incubation of the protein at alkaline pH conditions. A number of
bacterial ACP structures are known: Escherichia coli, Bacillus subtilis
[12] andMycobacterium tuberculosis [13]. So far, only one structure of
a mitochondrial ACP is available from Toxoplasma gondii [14].
Following discovery and identiﬁcation of ACPMs, further studies
suggested that mitochondria contain all necessary enzymes for fatty
acid biosynthesis and that they are able to synthesize short-chain fatty
acids [15,16]. ACPM was postulated to be involved in the synthesis of
octanoic acid as a precursor for lipoic acid in pea [17], A. thaliana [18],
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brucei [22]. Lipoic acid is an important prosthetic group of some
mitochondrial enzymes such as the pyruvate dehydrogenase and 2-
oxoglutarate dehydrogenase complexes [23,24]. There are also
indications for the synthesis of longer fatty acids [17,18]. It was
speculated that this activity plays a vital role, most likely for repair of
mitochondrial lipids [15].
Typically, the number of mitochondrial acyl carrier proteins in
eukaryotes ranges from one to three. However it seems that in most
eukaryotes two isoforms are found [25]. In mammalian [10] and N.
crassa [26] mitochondria one ACP homologue is found to be tightly
associated withmitochondrial complex I, whereas in Arabidopsis none
of three ACPM isoforms seems to be tightly associated with complex I
[27]. Also in mammalian mitochondria a fraction of the mitochondrial
ACP has been found in the mitochondrial matrix separate from
complex I [28].
Complex I (NADH:ubiquinone oxidoreductase) is the ﬁrst electron
transferring protein complex of the mitochondrial respiratory chain
and is one of the largest and most intricate membrane bound protein
complexes known [29]. The L-shaped molecule is composed of an
intrinsic membrane arm extending into the lipid bilayer and a
peripheral arm protruding into the matrix space. The atomic structure
of the hydrophilic part of the homologous enzyme from Thermus
thermophilus has been solved [30]. Nonetheless, the catalytic
mechanism of complex I is still not understood. Mitochondrial
complex I catalyses transfer of two electrons from reduced nicotin-
amide adenine dinucleotide (NADH) via ﬂavin mononucleotide
(FMN) and eight iron-sulfur clusters to ubiquinone. This transfer is
coupled to the translocation of four protons across the inner
mitochondrial membrane. The minimal set of 14 central subunits
that makes up the prokaryotic enzyme is extended signiﬁcantly by up
to 31 accessory subunits in eukaryotes adding up to a mass of about 1
MDa [31,32]. In mammals and fungi, seven hydrophobic central
subunits are encoded in the mitochondrial genome while the rest of
the subunits are nuclear coded. A number of mutations in complex I
subunit genes are known to be associated with neurodegenerative
diseases, including Parkinson's disease, LHON and Leigh syndrome
[33,34].
We have established Yarrowia lipolytica [35] as a useful yeast
genetic model to study mitochondrial complex I. To obtain further
insight into the role of ACPMs and their relationship to mitochondrial
complex I we analyzed the function of the two ACPM homologues
found in the genome of the strictly aerobic yeast Y. lipolytica.
2. Material and methods
2.1. Deletion of ACPM genes in Y. lipolytica
Using the sequences from the Genolevures website (http://cbi.
labri.fr/Genolevures/ index.php), we identiﬁed the ACPM homolo-
gues YALI0D14850g (ACPM1) and YALI0D24629g (ACPM2). 2.70 kb of
genomic DNA, comprising the complete ACPM1 open reading frame
(two exons) and 0.97 kb of 5′ and 0.96 kb of 3′ ﬂanking DNA was
ampliﬁed with primers TACTCGGCTGAACTGCAAG and ATCT-
CACGGCTTCACAACG. 3.08 kb of genomic DNA, comprising the
complete ACPM2 open reading frame (three exons) and 0.67 kb of
5′ and 0.66 kb of 3′ ﬂanking DNA, was ampliﬁed using primers
GTACAGAAGTGTCG GCGCAG and CTCGCTCTAACGCCGTACTC. Both
PCR products were made using Taq DNA polymerase (Sigma) and
genomic DNA from Y. lipolytica strain E129 and cloned into plasmid
pCR2.1 (Invitrogen). Deletion strains for the ACPM subunits of
complex I from Y. lipolytica were generated by homologous recom-
bination using the one-step transformation method as described [36].
Deletion alleles in which the ACPM ORFs are replaced with the URA3
marker gene were created as follows: First, genomic DNA fragments
were transferred into the single EcoRI site of vector pUB44(Supplemental Fig. S1). Then, the ACPM1 construct was gapped by
PCR, using primers AAGTCGACACGGACAGGATTCGAAC and ATGGATC-
CAGCGTTAAGGCCACAG, thereby removing the ORF together with
143 bp of 5′ ﬂanking sequence and 22 bp of 3′ ﬂanking sequence.
Similarly, the ACPM2 construct was gapped by PCR, using primers
AAGTCGACAGTGTGGAGGATGGTGTGG and AAGGATCCTCAAACAGAC-
TAAAGCCCTG, thereby removing the ORF together with 16 bp of 5′
ﬂanking sequence and 4 bp of 3′ ﬂanking sequence. PCR products
were digested with BamHI and SalI (sites underlined) and ligated
with the Y. lipolytica URA3 marker gene as a 1.7 kb BamHI/SalI
fragment, such that the orientation of the marker was opposite to the
original ORFs. The resulting constructs were linearized with NotI and
transformed into the diploid Y. lipolytica strain GB14 (NUCM-Htg2,
NDH2i, ura3-302, leu2-270, lys11/+, his1/+). Heterozygous deletion
strains in which one of the chromosomal copies of either ACPM1 or
ACPM2 had been replaced with the URA3 marker by double
homologous recombination (Supplemental Fig. S1) were selected
for their ability to grow in the absence of uracil and their inability to
grow in the presence of hygromycin B. Sporulation, followed by
random spore selection for the same markers was performed both in
the presence and absence of 10 μg/ml lipoic acid. Deletion strains
carrying a functional copy of the respective ACPM gene on replicative
plasmid pUB4 [37] were used as controls and will be referred to as
parental strains here.
2.2. Exchange of the phosphopantethein binding serines
ACPM ORFs with ﬂanking regions were ampliﬁed as described
above and cloned into plasmid pUB4. Mutations leading to the
exchange of the phosphopantethein binding serines for alanines were
carried out by PCR using primers GCCTTAGACACCGTCGAGGTTG and
GTCGAGGTTGAGGTCCTTGG (ACPM1-S66A); GCTTTGGATGTCGTC-
GAGGTG and GTCCAGACCAAGGTCGGAAG (ACPM2-S88A). Subse-
quently, the mutated genes were transformed into ACPM1/acpm1Δ
and acpm2Δ strains, respectively.
2.3. Tagged versions of ACPMs
For production of ACPM1-strepII primers AGGATGAGACCATTTAG-
CATCGGGCTGG and CAATTTGAAAAATAAGCAAGCTGTATATAATAG,
and for production of ACPM2-ﬂag primers GTCTTTGTAATCAACGGC-
TGGGTTAGTAGG and GATGATGATAAATAATCAACC TCAAACAGAC
were used. As a result ACPM ORFs were extended by 8 amino acids
at the C-termini: ACPM1 by WSHPQFEK and ACPM2 by DYKDDDDK.
Plasmids carrying tagged versions of ACPM genes were transformed
into diploid acpmΔ strains carrying one wild-type and one acpm::
URA3 allele. Complemented haploid deletion strains were obtained
by sporulation and random spore selection.
2.4. Preparation and analysis of complex I
For large scale puriﬁcation of complex I, Y. lipolytica was grown
at 27 °C in a 10-litre Biostat E fermenter (Braun, Melsungen,
Germany). Freshly harvested cells, or cells shock frozen at −80 °C,
were used for mitochondrial membrane preparations as described
[38] with the modiﬁcation that cells were broken up in a cooled
glass bead mill (Bernd Euler Biotechnology, Frankfurt, Germany).
Complex I was puriﬁed from mitochondrial membranes that were
solubilised with n-dodecyl-β-D-maltoside as described [39] with
slight modiﬁcations. Puriﬁcation was achieved by Ni2+-afﬁnity
chromatography with a modest reduction of the imidazole concen-
tration from 60 mM to 55 mM in the equilibration and washing
buffer and subsequent gel ﬁltration using a TSK4000 column.
Measurements of NADH:HAR and dNADH:DBQ oxidoreductase
activities were carried out as detailed in [40]. The mean values of
three measurements are given.
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Intact mitochondria from Y. lipolyticawere prepared essentially by
the enzymatic digestion method described in [41]. Brieﬂy, Y. lipolytica
cells were harvested at the early logarithmic stage (OD∼3-4). The cell
wall was weakened by 5 mM dithiothreitol and digested with
Zymolyase 20T (from Arthrobacter luteus, ICN Biomedicals). The
resulting spheroplasts were disrupted by 20 gentle strokes in a
loosely ﬁtting Dounce homogenizer and centrifuged at 2000g for
10 min. Mitochondrial fractions were collected by centrifugation of
the supernatant at 7000g for 20min. Crudemitochondria were further
puriﬁed on a sucrose step gradient as described in Ref. [42].
2.6. Mitochondrial fractionation
Intact mitochondria corresponding to 500 μg of protein deter-
mined according to a standard protocol [43] were suspended in 170 μl
1 mM EDTA, 20 mM Na+/Mops pH 7.2, subjected to 3 cycles of
freezing and thawing using liquid nitrogen and centrifuged for 1 h at
100,000g. The supernatant (containing matrix and intermembrane
space components) was transferred to another tube and 80 μl of gel
loading buffer I (0.03% Serva Blue G, freshly added 6% 2-mercap-
toethanol, 30% glycerol, 12% SDS, 150 mM Tris-Cl pH 7.0) was added.
The pellet (containing inner and outer membrane components) was
resuspended in 250 μl gel loading buffer I/3 (buffer I diluted 3 times in
water). The ﬁnal protein concentration of the supernatant and pellet
samples was 2 mg/ml. Also a sample of total mitochondria with the
same protein concentration was prepared.
2.7. Gel electrophoresis and western blotting
To investigate expression and localization of tagged ACPMs,
soluble and membrane fractions of mitochondria were resolved by
Tricine-SDS-PAGE according to [44]. 2D (BN/SDS) PAGE was used to
visualize respiratory chain complexes. Mitochondrial membranes
corresponding to 500 μg of total protein were solubilised with 3 g/g
digitonin and 500 mM amino caproic acid. Native protein complexes
were separated in the ﬁrst dimension using 4–13% gradient gels [45].
Gel stripes were excised, incubated in 1% SDS solution for 30 min and
put on 16% SDS gels. Tricine dSDS-PAGE was used to separate the
subunits of complex I from Y. lipolytica [46]. Proteins were separated
in the ﬁrst dimension using 6 M urea and 10% polyacrylamide SDS-
PAGE and in the second dimension using 16% polyacrylamide SDS-
PAGE. Silver staining was performed according to Rabilloud [47].
Proteins were transferred to polyvinylidendiﬂuoride membranes
(Immobilon TMP, Millipore) using a semidry immunoblotting
procedure. Membranes were incubated with the following antisera,
diluted in PBS buffer (270 mM NaCl, 5 mM KCl, 15 mM Na2HPO4,
3mMKH2PO4, pH 7.5) with 0.1% (w/v) Tween20: ACPM1-strepII with
mouse monoclonal anti-strepII-tag antibody (Qiagen); ACPM2-ﬂag
with anti-ﬂag (Sigma); aconitase with rabbit polyclonal antiserum
(kind gift of R. Lill, Marburg); hexokinase with rabbit polyclonal
antiserum, directed against the peptide SRKGSMADVPRDLLC (Sigma),
complex I subunits NESM, 39-kDa, 49-kDa and 51-kDa with mouse
monoclonal antibody (kind gift of V. Zickermann). All secondary
antibodies were peroxidase conjugated rabbit anti-mouse or anti-
rabbit IgG. Signals were detected using enhanced chemiluminescence
(Sigma).
2.8. Matrix-assisted laser desorption ionization time of ﬂight mass
spectrometry (MALDI-TOF-MS)
Stained protein spots were excised from dSDS gels and treated
following the protocol of [48]. The proteins were cleaved with trypsin
(12.5 ng/μl) in digestion buffer containing 25 mM ammonium
hydrogen carbonate, 5 mM CaCl2 at 37 °C over night.Spectra were recorded in the positive ion mode with a Ultraﬂex
MALDI TOF-TOF MS Instrument (Bruker Daltonics). The samples were
deposited on preparative plates by the fast evaporation method. DHB
(2,5-dihydroxybenzoic acid) or HCCA (4-hydroxy-α-cyano-cinnamic
acid) from Sigma were used as a matrix. Spectra were calibrated
internally using bovine trypsin autolysis products (m/z 805.4167 and
2163.0567) or, if necessary, externally using a reference peptide
mixture of bradykinin, angiotensin II, insulin (oxidized B chain),
adrenocorticotropic hormone (ProteoMass Peptide MALDI-MS Cali-
bration Kit, Sigma) covering the m/z 757.3997-3494.6513 range.
MALDI spectra were analyzed by the Mascot software package
(Matrix Science Ltd., London), Prowl software package (Proteo-
Metrics, LLC, New York, USA).
2.9. Sequence analysis
DNA and protein sequences were analyzed using the Vector NTI
(Informax) software. Homology searches of mammalian and fungal
databases were done using the BLAST server at http://www.ncbi.nlm.
nih.gov/BLAST/. Alignments of fungal and mammalian proteins were
generated using the program CLUSTALW at http://www.ebi.ac.uk/
clustalw/index.html. Searches of the NCBI conserved domains
database [49] were performed at the NCBI server (www.ncbi.nlm.
nih.gov/structure/cdd/wrpsb.cgi).
2.10. HPLC analysis of mitochondrial phospholipids
Mitochondrial lipids were analyzed by high performance liquid
chromatography (HPLC) as described by Richers and Hunte (manu-
script in preparation). In short, lipids were extracted from mitochon-
drial membranes according to Folch [50] with twomodiﬁcations. After
mixing a 50-μl sample with 950 μl chloroform/methanol (2/1, v/v),
phase separationwas induced by the addition of 200 μl HCl(aq) (0.1M)
instead of the original recommended salt solutions. Furthermore two
additional cycles of washing of the aqueous phase with the organic
phase increased the yield. The combined organic phases were dried
and redissolved in chloroform/methanol (4/1, v/v). The strains
acpm2Δ and acpm2Δ, pACPM2-S88A were compared to the parental
and the nubmΔ strain with a known complex I assembly defect. The
comparison was performed with four different starting materials: Y.
lipolytica cells, mitochondrial membranes, intact mitochondria and
sucrose gradient puriﬁed intact mitochondria [51]. The phospholipids
were separated by normal phase chromategraphy with a solvent
system of chloroform/ methanol/water/ammonia based on the
method described by [52]. An evaporative light scattering detector
(Sedex 75, Sedere) supplied with 3.3 bar nitrogen and heated to 80 °C
detected the phospholipids. Phospholipids were quantiﬁed by
external calibration with commercially available standards: 1,1′,2,2′-
tetraoleoyl cardiolipin; 1,2-dipalmitoyl-sn-glycero-phosphoethanola-
mine; L-α-phosphatidylinositol (soybean); 1,2-dipalmitoyl-sn-
glycero-phosphate; 1,2-dipalmitoyl-sn-glycero-phosphocholine; LPE
lysophosphatidylethanolamine; LPI lysophosphatidylinositol; LPA
lysophosphatydic acid; LPC lysophosphatidylcholine (all from Sigma).
3. Results
3.1. Deletion of the genes for ACPM1 and ACPM2 has severe effects
In order to investigate the function of the ACPMs we deleted the
two homologues of the S. cerevisiae gene for the mitochondrial acyl
carrier protein (YKL192c) that we had identiﬁed in the Y. lipolytica
genome as YALI0D14850 g (ACPM1) and YALI0D24629g (ACPM2). To
minimize the risk of selection for second site repressors during
homologous recombination, we transformed the linearized deletion
constructs into the diploid Y. lipolytica strain GB1. In the case of
ACPM2, the desired diploid strain was conﬁrmed to be heterozygous
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haploid acpm2::URA3 deletion strain (data not shown).
While we also successfully generated a diploid ACPM1/acpm1::
URA3 deletion strain, subsequent extensive sporulation attempts
failed to generate haploid strains carrying the ACPM1 deletion allele.
However, when a plasmid-borne, functional copy of the ACPM1 gene
was introduced into the ACPM1/ acpm1::URA3 strain prior to the
sporulation, haploid acpm1Δ, pACPM1 strains could be isolated. This
demonstrated successful complementation of the deletion allele and
excluded that second-site genetic defects in the diploid heterozygous
deletion strain had prevented formation of viable haploid deletion
spores. We thus concluded that ACPM1 is an essential gene in Y.
lipolytica. To discriminate whether the ACPM1 protein as a whole or
just its functional group was required for survival we exchanged
serine-66 of ACPM1 with alanine. This serine is conserved in all acyl-
carrier proteins and known to bind the phosphopantethein moiety. A
plasmid-borne copy of ACPM1-S66A was transformed into the
heterozygous ACPM1/acpm1::URA3 strain, but in contrast to the
wild-type copy it failed to complement the deletion phenotype and no
acpm1Δ,pACPM1-S66A spores were obtained. Thus the single amino
acid exchange seemed to have the same effect as complete removal of
the ACPM1 gene.
In contrast, ACPM2 was found to be not essential in a strain
carrying NDH2i to complement for complex I deﬁciency and a haploid
ACPM2 deletion strain (acpm2Δ) was obtained. To test whether
complex I was affected by deletion of the ACPM2 gene, we ﬁrst
measured its activities in mitochondrial membranes prepared
from the deletion strain and compared them to the parental strain
(Table 1). Speciﬁc inhibitor sensitive dNADH:DBQ oxidoreductase
activity was lost completely. A strong decrease in dNADH:HAR
oxidoreductase activity down almost to a level typically observed
with other complex I deﬁcient strains suggested that the loss of
complex I activity was due to a very low content of complex I.
Remarkably, essentially the same loss in activity was observedwhen a
mutated copy of the ACPM2 gene was introduced on a plasmid in
which the phosphopantethein binding serine-88 was replaced by
alanine. The loss of complex I was conﬁrmed when mitochondrial
membranes from the acpm2Δ strain and the parental strain were
analyzed by two-dimensional BN/SDS-PAGE (Fig. 1A). In contrast to
the parental strain no complex I could be detected by silver staining in
the ACPM2 deletion strain (Fig. 1B). The same result was obtained
with the mutant version lacking serine-88 (Fig. 1C). The pattern of the
other respiratory chain complexes VD, VM, III, IV, II and the presence of
small amounts of subcomplex F1, corresponding to the matrix part of
complex V [53] were not affected by the deletion, except that complex
IV was below the detection limit in the acpm2Δ strain (Fig. 1).
For higher sensitivity and to detect low amounts of possible
subcomplexes of complex I we further analyzed mitochondrial
membranes from the acpm2Δstrain by Western blotting of native
gels with different antibodies directed against subunits of complex I
(Fig. 2). In membranes from the parental strain fully assembled
complex I was found to be the dominant form. In addition, several
supercomplexes containing complex I together with complexes IIITable 1
Catalytic activities of mitochondrial membranes and complex I.
Parental acpm2Δ
μmol min−1mg−1
Mitochondrial membranes
NADH:HAR oxidoreductase 0.75 0.18
dNADH:DBQ oxidoreductase 0.27 b0.1
Puriﬁed complex I
NADH:HAR oxidoreductase 45 n.da
dNADH:DBQ oxidoreductase 3.4 n.d
a not determined.and/or complex IV were detected as described recently [54]. Some
disintegration of complex I into subcomplexes was also observedwith
monoclonal antibodies directed against the 51-kDa and 49-kDa
subunits of the peripheral arm and the accessory NESM subunit of
the membrane arm. With mitochondria from the ACPM2 deletion and
the S88A mutant strain a very small amount of fully assembled
complex I was detected with all three antibodies. However, only with
the antibody directed against the NESM subunit pronounced signals of
two putative subcomplexes were observed. These subcomplexes
migrated in a similar position as the disintegration products observed
with the parental strain at about 700 (marked ❶) and 300 kDa
(marked❷), but the fact that they were not detectable by the anti-51-
kDa and anti-49-kDa antibodies in the ACPM2-mutant strains
suggested a different composition. Rather, the antibodies directed
against the 51-kDa and 49-kDa subunits gave strong signals over a
broad range of molecular masses that were even more pronounced in
the ACPM2-mutants. These signals probably reﬂected the individual
subunits and/or small subcomplexes containing the respective
subunits. Unfortunately, due to the very small amounts available, it
was not possible to further analyze the subunit composition of the
subcomplexes.
3.2. Deletion of ACPM2 has no effect on the phospholipid composition
of mitochondria
To see whether deletion and mutagenesis of ACPM2 had affected
the lipid composition, we analyzed the phospholipid content of
extracts from mitochondrial membranes of parental, acpm2Δ,
acpm2Δ, pACPM2-S88A and the nubmΔ strains by HPLC. The nubmΔ
strain carrying a deletion of the central 51-kDa subunit of complex I
was included as additional control because of its severe complex I
assembly defect [55]. Fig. 3 shows that all lipids were present at very
similar ratios in intact, sucrose gradient-puriﬁed mitochondria from
all strains. Prominent peaks were identiﬁed by MALDI-MS as
cardiolipin, phosphatidyl-ethanolamine, phosphatidyl-inositol, lyso-
phosphatidyl-ethanolamine, phosphatidyl-choline. It should be noted
that the peak for LPE was found at a mass of 454.33 Da indicating
substitution with a palmitoyl-chain (16:0; theoretical mass
454.29 Da) rather than an unsaturated acyl-chain. Moreover, a strong
unidentiﬁed anion peak was observed at a mass of 924.81. Also the
protein to phospholipid ratio was nearly identical in mitochondria
from all strains (not shown). In addition, the analysis was performed
with whole cells, mitochondrial membranes and crude intact
mitochondria yielding very similar results (data not shown).
3.3. ACPM1 and ACPM2 are bona ﬁde subunits of Y. lipolytica complex I
Wenext addressed the questionwhether one or both of the ACPM-
proteins in Y. lipolyticawere bound to complex I as accessory subunits.
In a previous proteomic approach aimed at the identiﬁcation of the
accessory subunits of Y. lipolytica complex I we had already identiﬁed
ACPM1 as a component of the puriﬁed enzyme by MALDI-TOF mass
spectrometry [56]. However, the almost complete loss of fullyacpm2Δ::pS88A ACPM1-strepII ACPM2-ﬂag
0.17 0.81 0.77
b0.1 0.31 0.30
n.d 50 48
n.d 3.1 3.0
Fig. 1. 2D-BN/SDS PAGE analysis of Y. lipolyticamitochondrial membranes. Protein complexes were resolved by BN-PAGE in the ﬁrst and by 16% SDS-PAGE in the second dimension.
(A) A typical pattern of the parental strain respiratory chain complexes visible from left to right with decreasing molecular weight: ATP synthase dimer (VD), complex I, complex V
monomer (VM), complex III, F1 part of complex V (F1), complex IV and complex II. (B) acpm2Δ strain and (C) acpm2Δ:: pACPM2-S88A strain exhibit lack of complex I assembly. Other
respiratory complexes appear to assemble normally except that complex IV was below the detection limit in the acpm2Δ strain.
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suggested a tight link between complex I and ACPM2 as well. Indeed,
thorough analysis of the double-spot in dSDS-PAGE that had
previously been shown to contain ACPM1 (Fig 4A) allowed the
unambiguous identiﬁcation of bothACPM1andACPM2byMALDI-MS/
MS sequencing of peptides from both proteins (Supplemental Fig. S2).Fig. 2. Complex I subcomplexes in acpm2Δ and the acpm2Δ,pACPM2-S88A strains. Western
and acpm2Δ, pACPM2-S88A is shown. In the parental strain predominantly fully assemble
complex IV were detected (S, [54]) but not analyzed in detail here. Subcomplexes were dete
NESM subunit in the parental strain. In strains acpm2Δ and pACPM2-S88A only the antibod
suggesting that different subcomplexes of similar size but different composition were de
subunits of the peripheral arm were detected close to the front of the gel and only minute a
indicated by arrows: VD, complex V dimer: I, complex I; VM, complex V monomer; III2, comTo conﬁrm this assignment we introduced tagged versions of the
two proteins into the ACPMdeletion strains. Both constructs appeared
to be functional, since ACPM1-strepII permitted survival of strain
acpm1Δ (Fig. 4B) and ACPM2-ﬂag restored normal assembly of
complex I (Fig. 4C). Also NADH:HAR oxidoreductase and dNADH:
DBQ oxidoreductase activities of mitochondrial membranes fromblot analysis of mitochondrial membranes from the parental strain and strains acpm2Δ
d complex I and several supercomplexes of complex I associated with complex III and
cted at positions marked ❶ and ❷ by antibodies against the 51-kDa, the 49-kDa and the
y against the membrane arm subunit NESM indicated subcomplexes in these positions
tected. In strains acpm2Δ and pACPM2-S88A the majority of the 49-kDa and 51-kDa
mounts of fully assembled complex I were identiﬁed. Respiratory chain complexes are
plex III dimer; IV, complex IV; II, complex II.
Fig. 3.HPLC proﬁles of phospholipids extracted from Y. lipolyticamitochondria. Extracts
from sucrose gradient puriﬁed intact mitochondria (0.5 mg/ml) of the parental,
acpm2Δ acpm2Δ,pACPM2-S88A and nubmΔ strains were analyzed. No signiﬁcant
difference in phospholipid composition among the analyzed strains was found. CL,
cardiolipin; PE, phosphatidylethanolamine; PI, phosphatidylinositol; LPE, lysopho-
sphatidylethanolamine; PC, phosphatidylcholine; ⁎, pass through.
Fig. 5. Localization of tagged versions of ACPM in mitochondrial fractions. Intact
mitochondria were fractionated into soluble (ms) and membrane (mm) part and
analyzed for ACPM presence with antibodies speciﬁc to strepII- and ﬂag-tags. Neither of
them could be detected in the soluble fraction of mitochondria nor in the cytosolic
(PMS) fraction. Both ACPMs were detectable in the membrane fraction. Puriﬁed
complex I (CI) and whole mitochondria (mt) were used as controls. Antiserum speciﬁc
to representative proteins of each fraction were used: aconitase (soluble fraction),
hexokinase (cytosol) and NESM (complex I, membrane fraction).
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(Table 1). Moreover, also the puriﬁed complexes from both tagged
strains exhibited wild-type catalytic activities indicating normal
stability of the multiprotein complex. This allowed dSDS-PAGE
analysis of the tagged complexes. Molecular mass shifts of ACPM1-
strepII (Fig. 4B) and ACPM2-ﬂag (Fig. 4C) subunits as compared to the
untagged parental strain (Fig. 4A) conﬁrmed the assignment of the
two proteins that thus have both to be considered bona ﬁde subunits
of complex I in Y. lipolytica.
3.4. ACPM1 and ACPM2 are only found in the membrane fraction
of mitochondria
We then asked whether the two ACPMs were exclusively present
as complex I subunits in Y. lipolyticamitochondria. We isolated intact
mitochondria from the Y. lipolytica strains containing the tagged
versions of ACPM1 and ACPM2 and analyzed soluble and membrane
fractions by Western blotting (Fig. 5). As controls for the identity and
purity of the individual fractions we used aconitase for the
mitochondrial matrix, hexokinase for the cytosol and the complex I
subunit NESM for the mitochondrial membranes. Both ACPMs were
exclusively detectable in the membrane fraction but absent in the
soluble fraction of mitochondria and the cytosolic fraction (PMS). ThisFig. 4. Analysis of tagged versions of ACPMs in puriﬁed complex I by dSDS-PAGE. Both ACPM g
the two proteins. Molecular mass shifts as compared to the parental strain (A) are visible
arrows).strongly suggested that all ACPM1 and ACPM2 in mitochondria from
these strains were completely bound to complex I in the inner
mitochondrial membrane of Y. lipolytica.
4. Discussion
Individual deletion of the genes for the two mitochondrial acyl-
carrier protein homologues ACPM1 and ACPM2 revealed that both
proteins serve important functions in Y. lipolytica. While in the
absence of ACPM2 only trace amounts of fully assembled complex I
could be detected in mitochondrial membranes, ACPM1 even seems
to be indispensable for survival. This clear difference is quite
remarkable considering that the mature forms of the two proteins
are of very similar size [56] and exhibit a sequence similarity of 81%
with 63% identical amino acids (Supplemental Fig. S3). Despite of this
similarity, no or only partial cross-complementation between the two
genes was observed. The fact that ACPM1 turned out to be essential
for survival of Y. lipolytica indicated an important role for viability that
could not be compensated by ACPM2. In return the role of ACPM2 in
assembly and stability of mitochondrial complex I could not be takenenes were deleted and replaced with plasmid-borne copies encoding tagged versions of
in dSDS-PAGE of ACPM1-strepII (B) and ACPM2-ﬂag (C) complex I (both marked by
158 K. Dobrynin et al. / Biochimica et Biophysica Acta 1797 (2010) 152–159over by ACPM1. Two scenarios could accommodate these ﬁndings. On
one hand it could be envisioned that the two mitochondrial acyl-
carrier proteins have entirely different and independent functions.
Considering their very high similarity and the fact that neither of the
proteins seems to contain functional domains not present in the other,
this would be quite remarkable. Alternatively, the two proteins could
operate together e.g. by forming a heterodimer responsible for both
functions. In this case, onewould have to postulate that in the deletion
strains a homodimer of ACPM1 but not of ACPM2 could be formed to
take over the function essential for survival and that on the other
hand, both proteins would be necessary for complex I assembly and
stability. Favouring a similar function for ACPM1 and ACPM2, we also
found that removal of the conserved phosphopantethein carrying
serines in either of the two proteins had the same effect as deletion of
the complete reading frame. It should be noted here that we have
shown in a previous study that both proteins carry an additional mass
of about 560 Da consistent with the binding of phosphopantetheine-
hydroxy-tetradecanoate [56].
The observation that the residue binding the phosphopantethein
moiety is of critical importance was in line with the postulated role of
the ACPMs in the lipid metabolism of mitochondria. Indeed, it has
been reported that disruption of the ACPM subunit of complex I from
N. crassa results in a four-fold increase of lysophospholipids in
mitochondrial membranes [57]. However, in the ACPM2 deletion
strain of Y. lipolytica we could not observe any changes in the
phospholipid composition of the mitochondria.
In Y. lipolytica strains containing complex I both ACPMs were
found to be tightly and exclusively associated with complex I.
Suggesting a localization near the surface of complex I, association
of both proteins was not affected by attaching a C-terminal afﬁnity-
tag (Fig. 4) and no protein was detected in any mitochondrial
compartment other than the mitochondrial membranes (Fig. 5). This
is in striking contrast to the situation in other organisms analyzed so
far. In mammalian mitochondria, where the ACPM protein was ﬁrst
identiﬁed as the SDAP subunit of complex I [10], the major portion of
this protein is detectable in the mitochondrial matrix [28]. In Arabi-
dopsis none of the three ACPM isoforms seems to bind tightly to
complex I [27].
This suggests that the functionality of the ACPMs is independent of
their location, i.e. whether they are bound as subunits to complex I or
reside in the mitochondrial matrix. In fact, one has to conclude that
the ACPM1 protein was still present and functional even in the
absence of most of complex I in the acpm2Δ strain because ACPM1
was found to be required for survival of Y. lipolytica. Notably, ACPM is
also found in S. cerevisiae which does not contain mitochondrial
complex I and is devoid of all other complex I genes [58].
While ACPM1 seems to be an essential gene in Y. lipolytica, N.
crassa carrying a disrupted acp-1 gene–the only gene coding for an
ACPM protein in this organism [59]–is viable. The functional basis of
this observation remains unclear. With respect to assembly of
complex I the effects are similar in both organisms. Disruption of
the acp-1 gene in N. crassa results in lack of assembly of the peripheral
arm and improper assembly of the membrane part [57] and deletion
of the ACPM2 gene in Y. lipolytica results in a severe assembly defect of
complex I and appearance of subcomplexes (Fig. 2). In line with a role
in the stabilization of complex I, at least the ACPM homologous
subunit of bovine heart complex I seems to be associated with the
membrane arm of complex I: treating the puriﬁed complex from this
source with the chaotropic detergent lauryldimethylamine-oxide
splits it into subcomplexes Iα and Iβ that both comprise part of the
membrane arm and both contain SDAP [32].
Further studies will be required to understand why the deletion of
the ACPM1 gene is essential for survival and why deletion of the
highly similar ACPM2 gene is not. Differences between species seem
to suggest that the exact role of ACPMs in mitochondrial fatty acid
metabolism and complex I assembly may vary among species.Acknowledgements
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